Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postpartum Depression After Cesarean Delivery: Ketamine as a Preventative Intervention: A Feasibility Pilot-study

NCT04227704 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04227704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04227704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postpartum Depression After Cesarean Delivery: Ketamine as a Preventative Intervention: A Feasibility Pilot-study
Lead sponsor
Washington University School of Medicine
Phase
Phase 3
Overall status
Completed
Start date
November 12, 2020
Completion date
August 9, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum depression